Use of intrathecal baclofen in the treatment of patients with dystonia

Archives of Neurology

Volumn 53, Issue 12, 1996, Pages 1241-1246

  Ford, Blair ^a   Greene, Paul ^a   Louis, Elan D ^a,b   Petzinger, Giselle ^d   Bressman, Susan B ^a   Goodman, Robert ^a   Brin, Mitchell F ^c   Sadiq, Saud ^a   Fahn, Stanley ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

^b The New York Presbyterian Hospital   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d PARKINSON S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; DIAZEPAM; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID FISTULA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DYSTONIA; HEADACHE; HUMAN; INFUSION PUMP; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SPASTICITY; THALAMOTOMY;

EID: 0030467986     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550120049016     Document Type: Article

References (32)

1. Penn RD, Savoy S, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity: a double blind crossover study. N Engl J Med. 1989;320:1517-1521.
2. Lazorthes Y, Sallerin-Caute B, Verdie J, Bastide R, Carillo J. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg. 1990; 72:393-402.
3. Loubster PG, Narayan RK, Sandin KJ, et al. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia. 1991; 29:48-64.
4. Penn RD. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992;77:236-240.
5. Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen for spasticity of cerebral origin. JAMA. 1993;270:2475-2477.
6. Coffey RJ, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993;78:226-232.
7. Ochs GA. Intrathecal baclofen. Baillieres Clin Neurol. 1993;2:73-86.
8. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil. 1994;75:54-58.
9. Nance P, Schryvers O, Schmidt B, Dubo H, Loveridge B, Fewer D. Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci. 1995;22:22-29.
10. Becker WJ, Harris CJ, Long ML, Ablett DP, Klein GM, DeForge DA. Long-term intrathecal baclofen therapy in patients with intractable spasticity. Can J Neurol Sci. 1995;22:208-217.
11. SynchroMed Infusion System: Clinical Reference Guide. Minneapolis, Minn: Medtronic Inc; 1993.
12. Narayan RK, Loubster PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991;41:1141-1142.
13. Silbert PL, Stewart-Wynne EG. Increased dystonia after intrathecal baclofen. Neurology. 1992;42:1639-1640.
14. Concalves J, Garcia-March G, Sanchez-Ledesma MJ, Onzain I, Broseta J. Management of intractable spasticity of supraspinal origin by chronic cervical intrathecal infusion of baclofen. Stereotact Funct Neurosurg. 1994;62: 108-112.
15. Penn RD, Gianino JM, York MM. Intrathecal baclofen for motor disorders. Mov Disord. 1995;10:675-677.
16. Patterson V, Watt M, Byrnes D, Crowe D, Lee A. Management of severe spasticity with intrathecal baclofen delivered by a manually operated pump. J Neurol Neurosurg Psychiatry. 1994;57:582-588.
17. Azouvi P, Mane M, Thlebaut J-B, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil. 1996;77:35-39.
18. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 1985;35:73-77.
19. Hugenholtz H, Nelson RF, Dehoux E, Bickerton R. Intrathecal baclofen for intractable spinal spasticity - a double-blind cross-over comparison with placebo in 6 patients. Can J Neurol Sci. 1992;19:188-195.
20. Burke RE, Fahn S, Marsden CD. Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl. Neurology. 1986;36:160-164.
21. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain. 1992;8:338-345.
22. Teddy P, Jamous A, Gardner B, Wane D, Silver J. Complications of intrathecal baclofen delivery. Br J Neurosurg. 1992;6:115-118.
23. Saltuari L, Kronenberg M, Marosi MJ, et al. Indication, efficiency and complications of intrathecal pump supported baclofen treatment in spinal spasticity. Acta Neurol. 1992;14:187-194.
24. Delhaas EM, Brouwers JRB. Intrathecal baclofen overdose: report of seven events and review of the literature. Int J Clin Pharmacol Ther. 1991;29:274-280.
25. Seigfried RN, Jacobson L, Chabal C. Development of an acute withdrawal syndrome following the cessation on intrathecal baclofen in a patient with spasticity. Anesthesiology. 1992;5:1048-1050.
26. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS. Continuous intrathecal baclofen in spinal cord spasticity. Am J Phys Med Rehabil. 1992;71: 321-327.
27. Penn RD, York MM, Paice JA. Catheter systems for intrathecal drug delivery. J Neurosurg. 1995;83:215-217.
28. Akman MN, Loubser PG, Donovan WH, O'Neill RN, Rossi CD. Intrathecal baclofen: does tolerance occur? Paraplegia. 1993;31:516-520.
29. B receptors in the rat substantia gelatinosa. J Neurosurg. 1993;79:544-549.
30. Chabal C, Jacobson L, Terman G. Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen. Anesthesiology. 1992;76: 312-314.
31. Greene P, Kang UJ, Fahn S. Spread of symptoms in idiopathic torsion dystonia. Mov Disord. 1995;10:143-152.
32. Greene P. Baclofen in the treatment of dystonia. Clin Neuropharmacol. 1992; 15:276-288.